contains lesions without relying on traditional staining or lengthy pathology processes. The technology integrates with existing workflows—particularly bronchoscopy—to confirm lesion-in-tool, reduce indeterminate biopsies, and improve diagnostic yield. CellTivity’s tools preserve tissue integrity so samples remain usable for downstream analyses such as histology and next-generation sequencing.